Epigenome-Wide Association Studies Provide Insight into the Pathogenesis of Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis
Journal Title: Annals of Hepatology - Year 2018, Vol 17, Issue 1
Abstract
-
Authors and Affiliations
Aybike Birerdinc, Zobair M. Younossi
Efficacy of Triple Therapy with Thymalfasin, Peginterferon alpha-2a, and Ribavirin for the Treatment of Hispanic Chronic Hepatitis C, Nonresponders by Poo JL et al.
Fatigue and depressive symptoms associated with chronic viral hepatitis patients. health-related quality of life (HRQO
Background and rationale. It is well established that chronic viral hepatitis (CVH) negatively affects patients . health-related quality of life (HRQOL). The aim of the present study was to assess the extent to which fat...
Chronic hepatitis C treatment in näive patients
Hepatitis C (HCV) is a major public health problem worldwide and it is considered that there are about 180 millions of infected people. The natural history of hepatitis C shows that, of those individuals affected by a pr...
Hepatitis C antiviral long-term treatment against cirrhosis (HALT-C) trial
It is a comment of an article published in N Engl J Med. 2008;359:2429-41
Adipokines in a group of mexican patients with nonalcoholic steatohepatitis
Introduction: Leptin has been implicated in the pathogenesis of nonalcoholic steatohepatitis. It has also been suggested that adiponectin plays an important role in the transition from fatty liver disease to nonalcoholic...